• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: THE BINDING SITE LIMITED OPTILITE® ANALYSER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

THE BINDING SITE LIMITED OPTILITE® ANALYSER Back to Search Results
Model Number IE700
Medical Device Problem Code Use of Device Problem (1670)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 04/17/2024
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
From the information available to date, the failure was deemed to be caused by user error.The cleaning wipe material may have been introduced during daily maintenance on morning of the 17th of april.The optilite analyser returned results in line with patient history after removal of the cleaning material and performed as expected.The date of installation of the optilite analyser at the affected customer site is 06/19/2018.
 
Event or Problem Description
A customer contacted the binding site (pdx) on 18th of april 2024 to report that erroneous results (no values provided) on multiple assays running on the binding site optilite analyser had been released from the laboratory to the clinician on the (b)(6) 2024.The clinician identified that certain sample results for freelite kappa free kit (lk016.Opt.A) and freelite lambda free kit (lk018.Opt.A) were not in line with patient clinical history.The customer reported that cleaning wipe material was wrapped around the mixing paddle of the optilite analyser.The material was removed, samples were re-run and all results were corrected within the same day ((b)(6) 2024).On the 25th of april 2024 (manufacturer date of awareness), the customer provided values on affected samples from the (b)(6).A total of 179 results have been affected by this issue across nine different pdx assays.The assays impacted were freelite kappa free kit (lk016.Opt.A), freelite lambda free kit (lk018.Opt.A), beta-2-microglobulin (lk043.Opt.A), optilite® c3c kit (nk023.Opt.A), optilite® c4 kit (nk025.Opt.A), optilite® haptoglobin kit (nk058.Opt.A), optilite® iga kit (nk010.Opt.A), optilite® igm kit (nk012.Opt.A), optilite® igg kit (nk004.Opt.A).The customer confirmed that no reports have been received of harm to patients, change in patient management or inappropriate therapy due to the issue and all results were corrected on the day.The decision was taken to report as a matter of a caution as in one case on the free light chain (flc) kappa assay, if the error were to recur and results were used in isolation, there is a remote possibility of it leading to serious injury.For this sample, the initial result for the free light chain (flc) kappa falsely reported 174.51 mg/l.This result was above the total allowable error (tea) of 40% of the free light chain (flc) kappa assay.Upon rerun, the more accurate result of 43.73 mg/l (reference range: 3.30 - 19.40 mg/l) was obtained.If the initial result was used in isolation and the involved/uninvolved flc ratio is equal to or greater than 100, it could lead to a false diagnosis of myeloma and subsequent treatment.As per the instructions for use of the free light chain (flc) kappa assay (ins016.Opt.A) "diagnosis cannot be made, and treatment must not be given on the basis of kappa free light-chain and/ or lambda free light-chain measurements alone.Clinical history and other laboratory findings must be considered".
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
OPTILITE® ANALYSER
Common Device Name
OPTILITE® ANALYSER
Manufacturer (Section D)
THE BINDING SITE LIMITED
8 calthorpe road
edgbaston
birmingham, B15 1 QT
UK  B15 1QT
Manufacturer (Section G)
THE BINDING SITE LTD.
8 calthorpe road
edgbaston
birmingham, B15 1 QT
UK   B15 1QT
Manufacturer Contact
richard hughes
8 calthorpe road
edgbaston
birmingham, B15 1-QT
UK   B15 1QT
MDR Report Key19339251
Report Number9614373-2024-00002
Device Sequence Number8687681
Product Code JJE
UDI-Device Identifier05051700020893
UDI-Public05051700020893
Combination Product (Y/N)N
Initial Reporter StateWV
Initial Reporter CountryUS
PMA/510(K) Number
510K EXEMPT
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Health Professional,User Facility
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date (Section B) 05/17/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Model NumberIE700
Device Catalogue NumberIE700
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 04/25/2024
Initial Report FDA Received Date05/17/2024
Was Device Evaluated by Manufacturer? (Y/N) No
Is the Device Labeled for Single Use? (Y/N) No
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Reuse
Patient Sequence Number1
Outcome Attributed to Adverse Event Other;
Patient SexUnknown
-
-